According to the latest report by IMARC Group, titled “Global Biopharmaceutical Manufacturing Market Report 2020-2025”, the market is currently witnessing strong growth. The global biopharmaceutical manufacturing market size to exhibit moderate growth during the next five years. Biopharmaceutical manufacturing refers to the process of producing medical drugs using biological sources. It includes the production of vaccines, human growth hormones (HGH), purified proteins, monoclonal antibodies, interferon and recombinant hormones and proteins. The manufacturing involves chemical processing, filling and finishing operations, packaging, sterilization and quality checks. Biopharmaceutical manufacturing involves extensive research and development (R&D) activities and requires considerable scientific knowledge and infrastructure. It aids in enhancing sterilization, flexibility, cost-effectiveness and reducing cross-contamination risks.Get a sample copy of this Report: www.imarcgroup.com/global-biopharmaceutical-manufacturing-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Trends:
The global biopharmaceutical manufacturing market is primarily being driven by the increasing demand for biologics and biosimilars due to the increasing prevalence of chronic diseases. Moreover, various technological advancements, such as the integration of the Industrial Internet of Things (IIoT) with connected devices that enable the manufacturers to gain access to real-time data and visibility of operations, are providing a thrust to the market growth. Other factors, such as the increasing adoption of contract manufacturing services and rising healthcare expenditures, are anticipated to positively impact the market growth.
View Full Report with TOC & List of Figure: www.imarcgroup.com/global-biopharmaceutical-manufacturing-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
Hoffmann-La Roche Ltd
Amgen Inc.
Novo Nordisk A/S
AbbVie Inc.
Groupe Sanofi
Johnson & Johnson Services, Inc.
Pfizer Inc.
Merck & Co., Inc.
Eli Lilly and Company
Biogen Inc
Biopharmaceutical Manufacturing Market Segmentation:
Our report has categorized the market based on region, cell culture and class.
Breakup by Cell Culture:
Mammalian
Microbial
Breakup by Class:
Monoclonal Antibodies
Recombinant Proteins
Interferon
Granulocyte Colony-Stimulating Factor (G-CSF)
Erythropoietin
Recombinant Human Insulin
Vaccines
Human Growth Hormones (HGH)
Regional Insights:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain